Direkt zum Inhalt
Merck

Surgical management of placenta accreta: to leave or remove the placenta?

BJOG : an international journal of obstetrics and gynaecology (2014-01-01)
A Perez-Delboy, J D Wright
ZUSAMMENFASSUNG

Abnromalities of placentation, including placenta accreta, represent a major source of morbidity and mortality among women. Traditional management consists of peripartum hysterectomy at the time of delivery, although more conservative treatments have also been developed recently. In this review we describe the available literature describing the operative approach and considerations for management of women with placenta accreta.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
L-Amethopterin Hydrat, ≥98% (HPLC), powder
Sigma-Aldrich
L-Amethopterin Hydrat, powder, BioReagent, suitable for cell culture, ≥98% (HPLC)
Sigma-Aldrich
Methotrexat, meets USP testing specifications
Supelco
Methotrexat -Lösung, 1.0 mg/mL in methanol with 0.1N NaOH, ampule of 1 mL, certified reference material, Cerilliant®
Methotrexat, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
L-Amethopterin Hydrat, ≥99.0% (sum of enantiomers, HPLC)
Methotrexat für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard